|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| C12Q 1/68 |
| (11) | Number of the document | 2416778 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10712675.7 |
| Date of filing the European patent application | 2010-04-05 | |
| (97) | Date of publication of the European application | 2012-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/029943 |
| Date | 2010-04-05 |
| (87) | Number | WO 2010/117941 |
| Date | 2010-10-14 |
| (30) | Number | Date | Country code |
| 167139 P | 2009-04-06 | US |
| (72) |
LAVEDAN, Christian, US
VOLPI, Simona, US
LICAMELE, Louis, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037,
US
|
| (54) | METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION BASED ON ABCC2 GENE SEQUENCE OR PRODUCT THEREOF |
| METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION BASED ON ABCC2 GENE SEQUENCE OR PRODUCT THEREOF |